Our Team

Joaquín Martínez López

MD, PhD (President and Co-founder)

Dr. Joaquín Martínez-López who graduated in Medicine from the University of Granada in 1991, is the Head of the Haematology department at Hospital 12 de Octubre, Director of the Haematological Malignancies Research Unit at the Spanish National Cancer Research Centre (CNIO) and Professor at Universidad Complutense of Madrid. He has more than 200 publications in international peer-reviewed journals and belongs to the main international working groups of Myeloma, Lymphoma and other haematological cancers.

Santiago Barrio

PhD (CEO and Co-Founder)

Dr. Santiago Barrio, who graduated in Biochemistry and has a Master in Biophysics and a PhD in Biomedicine from the Universidad Complutense of Madrid, developed the applications for MRD monitoring during his PhD in the group of Dr. Joaquín Martínez-López. After five years of excellent post-doctoral research at the Mayo Clinic (USA) and the Wuerzburg University Clinic (Germany), Santiago returned to Spain to manage the start-up of this innovative business.

Luis Paz-Ares

MD, PhD (Co-Founder and Medical Director – Solid Tumours)

Dr. Luis Paz-Ares, who graduated in Medicine from the Universidad Autónoma of Madrid in 1986, is Head of the Oncology Department at Hospital 12 de Octubre since 2015 and Professor at the Universidad Complutense of Madrid since 2014. In addition to an extensive research activity with more than 250 scientific publications, he is a member of the main oncology societies, scientific committees and national and international working groups.

Rosa Ayala Díaz

(Co-Founder and Medical Director – Haematological Tumours)

Dr. Rosa Ayala who graduated in Medicine from the University of Salamanca in 1992, is the Head of the Molecular Biology Laboratory at Hospital 12 de Octubre in Madrid, where she combines her work with patients with an intense research activity with more than 200 scientific publications and communications in journals and international conferences. Her research in recent years has laid the foundations for the technology offered by Altum.

Yanira Ruiz Herida

(PhD, Chief Operating Oficcer)

Industrial PhD in Medicine from Universidad Complutense (Madrid). MsC in Computational Biology. She has experience developing and implementing novel experimental and data analysis protocols based on NGS. Prior to her role in Altum, she spent 4 years in a biotech as responsible for scientific and comertial strategy, as well as leading clients partnership. In Altum, she works on the design and execution of business operations and managing internal activities.

Laura Rufián Vázquez

(Lab. Manager)

Technical specialist in clinical diagnostic laboratory. She has participated in numerous projects of different research groups at Hospital 12 de Octubre, using and improving her knowledge in many innovative techniques. She works in the Translational Hematology Laboratory at Hospital 12 de Octubre since 2019, where she is responsible for NGS projects as well as for laboratory management.

Ricardo Sánchez

PhD (Project Manager)

Chemistry Graduate. Biochemistry Graduate. Molecular Biology PhD by the Universidad Autónoma of Madrid. Clinical Biochemistry Specialist. He started his research work studying two proteins involved in DNA repair by Nuclear Magnetic Resonance at Spanish Cancer Research Center (CNIO). Later, he prepared the Clinical Biochemistry training at Hospital 12 de Octubre and he is working as specialist in Molecular Onco-hematology since 2015. He has participated in several NGS research projects and is author or co-author of more than 20 international publications.

Sara Dorado

(Sofware Developer and Data Analyst)

Double BsC in Maths and Computing. MsC in Artifiial Intelligence for the Universidad Autónoma in Madrid. She has participated in international research projects as developer of matching learning algoriths. She is part of the Computer Science Department at University Juan Carlos III in Madrid. In Altum she has a key role in the development of advances bioinformatic tools based on matching learning algorithms by integration of multi-omics data and clinical variables.

Alexandra Juarez

(Lab Technician)

Specialist in molecular biology and Next Generation Sequencing. She has more than 12 years of experience developing molecular genetic test for the departments of Hematology and Genetics at Hospital 12 de Octubre in Madrid. She is also specialized in quality protocols implementation and maintenance of lab equipments. In Altum, she is responsable for quality manadgment system and NGS samples processing.

Marga Rodriguez

(Lab Specialist)

BsC in Biochemistry from the University Complutense of Madrid. MsC in Clinical Chemistry by Universidad San Pablo CEU. She has extensive experience working at pathology molecular labs integrated in the clinical setting. She has developed and performed PCR and NGS assays for the molecular characterization of solid tumors from liquid biopsy and FFPE samples.
In Altum, she is in charge of perfoming NGS assays for diagnostic and research services.

Alejandro Martín

(Bioinformatician)

Bachelor’s Degree in Biochemistry and Master’s Degree in Bioinformatics and Computational Biology. He has analized data from different next generation sequencing platforms and approaches: amplicon-based targeted sequencing, WES, WGS, and long-reads technologies such as PacBio and Nanopore.
In Altum he performs the management, analysis and report of multi-omic data. He also works on the development of a novel bioinformatic algorithm to improve our MRD test.

Luis Domínguez Moreno

(Strategic and Financial Advisor)

Bachelor’s Degree in Business Administration from Universidad Complutense of Madrid and MBA Executive from IE Business School. Luis has a 9-year experience as Finance Director in two companies, with subsidiaries abroad and including responsibilities in several areas such as HHRR, Warehouse, IT and Purchase. Currently, and for 8 years, he has been working in the Business Accelerator & Incubator of UC3M University Science Park, giving strategic and financial advice for its technological startups and spin-offs, including searching for public and prívate funding.

Request a quote